Roche is planning to move a new antibiotic into late-stage clinical trials after studies showed it had potential to tackle a ...

Swiss drugmaker Roche said on Monday it would advance testing of an antibiotic against a common drug-resistant bacteria that ...

Swiss healthcare company Roche (RHHBY) on Friday said that the European Medicines Agency’s Committee for Medicinal Products ...

Roche (OTCQX:RHHBY) (OTCQX:RHHBF) said that an advisory panel of the European Medicines Agency (EMA), endorsed its Itovebi ...

Roche’s plan to bolster Tecentriq’s position in small cell lung cancer with Jazz Pharmaceuticals’ Zepzelca has paid off. | ...

Roche, hoping to carve out a standard-of-care spot for its PI3K inhibitor Itovebi, now has another leg to stand on with new ...

Roche (RHHBF) unit Genentech partners Orionis Biosciences to develop and commercialize cancer drugs in a deal that exceed $2B ...

Orionis to receive $105 million upfront, as well as future milestone-related payments. Orionis will leverage its Allo-Glue™ platform for the discovery of small-molecule monovale ...

A group of advisers to the Food and Drug Administration said Roche Holding AG needs to study its blood cancer treatment in ...

La Roche-Posay, the worldwide expert in advanced UV protection, is dedicated to raising awareness on the importance of sun safety and making sunscreen a matter of public health. La Roche-Posay ...

La Roche-Posay is a trusted brand, offering an array of sunscreens, designed to cater to different skin requirements and types. When it comes to choosing the best La Roche-Posay sunscreen ...

The three sunscreens I tested out were Aldi’s Lacura SPF 30 Moisturising Sun Lotion (£2.79), E45 Sun Body Lotion 50+ (£14) and La Roche-Posay Anthelios UVMune 400 Invisible 50+ (£20).